Details for New Drug Application (NDA): 020720
✉ Email this page to a colleague
The generic ingredient in REZULIN is troglitazone. Additional details are available on the troglitazone profile page.
Summary for 020720
Tradename: | REZULIN |
Applicant: | Pfizer Pharms |
Ingredient: | troglitazone |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
Approval Date: | Jan 29, 1997 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 400MG | ||||
Approval Date: | Jan 29, 1997 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 300MG | ||||
Approval Date: | Aug 4, 1997 | TE: | RLD: | No |
Expired US Patents for NDA 020720
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer Pharms | REZULIN | troglitazone | TABLET;ORAL | 020720-001 | Jan 29, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer Pharms | REZULIN | troglitazone | TABLET;ORAL | 020720-002 | Jan 29, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer Pharms | REZULIN | troglitazone | TABLET;ORAL | 020720-002 | Jan 29, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer Pharms | REZULIN | troglitazone | TABLET;ORAL | 020720-003 | Aug 4, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer Pharms | REZULIN | troglitazone | TABLET;ORAL | 020720-001 | Jan 29, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer Pharms | REZULIN | troglitazone | TABLET;ORAL | 020720-003 | Aug 4, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer Pharms | REZULIN | troglitazone | TABLET;ORAL | 020720-002 | Jan 29, 1997 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription